Clinicians should recognize these agents as an important and underutilized tool when caring for this high-risk population. Luciana Veroza Viana, PhD, post-graduate program, Medical Sciences, Endocrinology, Federal University of Rio Grande do Sul, Porto Alegre, Brazil Looking ahead, the team is planning a long-term review of metabolic complications among their outpatient population with schizophrenia over the past two decades, a project led by Professor of Psychiatry Clarissa Gama and her student Luiza Sperb that aims to identify key factors associated with increased metabolic risk
Eddie is phenomenal when it comes to subtle enhancements
Book any morning, afternoon, or evening that works for you
10.1016/j.cpr.2009.05.003 48 McmahonL
Heidi Taipale, Ph.D., from the University of Eastern Finland in Kuopio, and colleagues examined the risk for worsening mental illness in people already diagnosed with depression, anxiety, or both, who were prescribed antidiabetic medications, including GLP-1 receptor agonists
Nutrition professionals are not optional in the GLP-1 era